查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
裘馨氏肌肉萎縮症治療的全球市場 (2022年～2028年):產業分析·規模·佔有率·成長·趨勢
市場調查報告書
商品編碼
1073306

裘馨氏肌肉萎縮症治療的全球市場 (2022年～2028年):產業分析·規模·佔有率·成長·趨勢

Global Duchenne Muscular Dystrophy Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028
出版日期: | 出版商: Value Market Research | 英文 258 Pages | 商品交期: 最快1-2個工作天內

價格

本報告提供全球裘馨氏肌肉萎縮症治療的市場調查，彙整市場概要，市場成長的各種影響因素分析，市場規模的轉變·預測，各種區分·地區/各主要國家的明細，競爭環境，主要企業簡介等資訊。

目錄

第1章 序文

第2章 摘要整理

第3章 裘馨氏肌肉萎縮症治療:產業分析

  • 簡介:市場動態
  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 產業趨勢
  • 波特的五力分析
  • 市場魅力

第4章 價值鏈分析

  • 價值鏈分析
  • 原料分析
  • 潛在的買主清單
  • 行銷流通管道

第5章 COVID-19:影響分析

  • COVID-19流行:影響分析
  • COVID-19影響分析:生產·進出口·需求
  • COVID-19前後的市場
  • COVID-19流行的估計的影響
  • COVID-19:微觀及宏觀因素的分析

第6章 全球裘馨氏肌肉萎縮症治療市場分析:各產品類型

  • 概要
  • 實際成果資料·預測資料
  • 分析:各產品類型
  • 銷售額實際成果·預測 (各地區):疼痛管理藥
  • 銷售額實際成果·預測 (各地區):皮質類固醇
  • 銷售額實際成果·預測 (各地區):NSAID

第7章 全球裘馨氏肌肉萎縮症治療市場分析:各用途

  • 概要
  • 實際成果資料·預測資料
  • 分析:各用途
  • 銷售額實際成果·預測 (各地區):突然變異抑制
  • 銷售額實際成果·預測 (各地區):埃克森skipping方法

第8章 全球裘馨氏肌肉萎縮症治療市場分析:各終端用戶

  • 概要
  • 實際成果資料·預測資料
  • 分析:各終端用戶
  • 銷售額實際成果·預測 (各地區):醫院
  • 銷售額實際成果·預測 (各地區):居家照護
  • 銷售額實際成果·預測 (各地區):診所

第9章 全球裘馨氏肌肉萎縮症治療市場分析:各地區

  • 地區預測
  • 銷售額分析:北美
  • 銷售額分析:歐洲
  • 銷售額分析:亞太地區
  • 銷售額分析:南美
  • 銷售額分析:中東·非洲

第10章 裘馨氏肌肉萎縮症治療企業的競爭情形

  • 市場競爭
  • 聯盟/合作/契約
  • M&A
  • 新產品的銷售
  • 其他的發展

第11章 企業簡介

  • 前十大企業的佔有率分析
  • 市場集中度
  • Acceleron Pharma Inc.
  • Akashi Therapeutics Inc.
  • BioMarin Pharmaceutical Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Janssen Pharmaceuticals Inc.
  • Lexicon Pharmaceuticals Inc.
  • Nippon Shokubai Co. Ltd.
  • Nobelpharma Co. Ltd.
  • Pfizer Inc.
  • PTC Therapeutics Inc.
  • Sarepta Therapeutics Inc.
  • Taiho Pharmaceutical Co. Ltd.
Product Code: VMR11218127

Value Market Research deeply researched the Global Duchenne Muscular Dystrophy Treatment Market to foresee a significant growth in the industry over the upcoming years. The global duchenne muscular dystrophy treatment market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global duchenne muscular dystrophy treatment market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this duchenne muscular dystrophy treatment market.

The next sections of the duchenne muscular dystrophy treatment market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

  • North America- United States, Canada, and Mexico
  • Europe- United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe
  • Asia-Pacific- China, India, Japan, South Korea, Australia & Rest of APAC
  • Latin America- Brazil, Argentina, Peru, Chile & Rest of Latin America
  • Middle East and Africa- Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below:

By Product Type

  • Pain Management Drugs
  • Corticosteroids
  • NSAIDs

By Application

  • Mutation Suppression
  • Exon Skipping Approach

By End User

  • Hospitals
  • Home Care Settings
  • Clinics

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . DUCHENNE MUSCULAR DYSTROPHY TREATMENT - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End User
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
  • 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL DUCHENNE MUSCULAR DYSTROPHY TREATMENT MARKET ANALYSIS BY PRODUCT TYPE

  • 6.1 Overview by Product Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product Type
  • 6.4 Pain Management Drugs Historic and Forecast Sales by Regions
  • 6.5 Corticosteroids Historic and Forecast Sales by Regions
  • 6.6 NSAIDs Historic and Forecast Sales by Regions

7 . GLOBAL DUCHENNE MUSCULAR DYSTROPHY TREATMENT MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 Mutation Suppression Historic and Forecast Sales by Regions
  • 7.5 Exon Skipping Approach Historic and Forecast Sales by Regions

8 . GLOBAL DUCHENNE MUSCULAR DYSTROPHY TREATMENT MARKET SALES ANALYSIS BY END USER

  • 8.1 Overview by End User
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End User
  • 8.4 Hospitals Historic and Forecast Sales by Regions
  • 8.5 Home Care Settings Historic and Forecast Sales by Regions
  • 8.6 Clinics Historic and Forecast Sales by Regions

9 . GLOBAL DUCHENNE MUSCULAR DYSTROPHY TREATMENT MARKET SALES ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook Sales Analysis
  • 9.2. Introduction Sales Analysis
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE DUCHENNE MUSCULAR DYSTROPHY TREATMENT COMPANIES

  • 10.1. Duchenne Muscular Dystrophy Treatment Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF DUCHENNE MUSCULAR DYSTROPHY TREATMENT INDUSTRY

  • 11.1. Top 10 Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Acceleron Pharma Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Akashi Therapeutics Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. BioMarin Pharmaceutical Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Bristol-Myers Squibb Company
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Eli Lilly and Company
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Janssen Pharmaceuticals Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Lexicon Pharmaceuticals Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Nippon Shokubai Co. Ltd.
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Nobelpharma Co. Ltd.
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Pfizer Inc.
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. PTC Therapeutics Inc.
    • 11.13.1. Company Overview
    • 11.13.2. Company Revenue
    • 11.13.3. Products
    • 11.13.4. Recent Developments
  • 11.14. Sarepta Therapeutics Inc.
    • 11.14.1. Company Overview
    • 11.14.2. Company Revenue
    • 11.14.3. Products
    • 11.14.4. Recent Developments
  • 11.15. Taiho Pharmaceutical Co. Ltd.
    • 11.15.1. Company Overview
    • 11.15.2. Company Revenue
    • 11.15.3. Products
    • 11.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Product Type (USD MN)
  • Pain Management Drugs Market Sales by Geography (USD MN)
  • Corticosteroids Market Sales by Geography (USD MN)
  • NSAIDs Market Sales by Geography (USD MN)
  • Analysis Market by Application (USD MN)
  • Mutation Suppression Market Sales by Geography (USD MN)
  • Exon Skipping Approach Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Home Care Settings Market Sales by Geography (USD MN)
  • Clinics Market Sales by Geography (USD MN)
  • Global Duchenne Muscular Dystrophy Treatment Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Duchenne Muscular Dystrophy Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Duchenne Muscular Dystrophy Treatment Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product Type (USD MN)
  • Pain Management Drugs Market Sales by Geography (USD MN)
  • Corticosteroids Market Sales by Geography (USD MN)
  • NSAIDs Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Mutation Suppression Market Sales by Geography (USD MN)
  • Exon Skipping Approach Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Home Care Settings Market Sales by Geography (USD MN)
  • Clinics Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.